Dose dense induction chemotherapy, two semi-high-dose conditioning autologous peripheral blood progenitor cell transplant and a non-myeloablative reduced intensity conditioning allogeneic stem cell transplants in patients with and without donor for lymph node 4+ and to the bone marrow metastasized breast cancer